Edgewise Therapeutics
EWTX
EWTX
200 hedge funds and large institutions have $2.64B invested in Edgewise Therapeutics in 2024 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 71 increasing their positions, 63 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
200
Holders Change
+24
Holders Change %
+13.64%
% of All Funds
2.66%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.12%
New
45
Increased
71
Reduced
63
Closed
20
Calls
$23.3M
Puts
$9.82M
Net Calls
+$13.4M
Net Calls Change
-$33.2M
Top Buyers
| 1 |
PBA
Paradigm Biocapital Advisors
New York
|
+$45.5M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$20.8M |
| 3 |
IHAM
Integral Health Asset Management
New York
|
+$14.7M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$11.4M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$9.98M |
Top Sellers
| 1 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$56.4M |
| 2 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$41.7M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
-$33.4M |
| 4 |
VA
VR Adviser
New York
|
-$26.7M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$14.7M |
